Status:
COMPLETED
Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
Beckman Laser Institute University of California Irvine
Conditions:
Skin Cancer
Signs and Symptoms
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate native tissue optical properties and photosensitizer optical properties in vivo with a novel, non-contact optical imaging device call Modulated Imaging to help...
Detailed Description
The current standard of care for skin cancer is excision, curettage and electrodesiccation and/or cryosurgery. The Modulated Imaging can measure tissue optical properties that effect the Photodynamic...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Biopsy proven diagnosis of a basal cell carcinoma in a non-facial area
Exclusion
- Age \< 18 years
- Pregnancy
- Breast feeding.
- photosensitivity
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00784108
Start Date
October 1 2008
End Date
September 1 2012
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beckman Laser Institute Medical clinic
Irvine, California, United States, 92612